Avricore Health Inc. buy krebskrebs
Start price
26.05.20
/
50%
€0.012
Target price
04.11.21
€0.010
Performance (%)
743.48%
End price
05.11.21
€0.097
Summary
This prediction ended on 05.11.21 with a price of €0.097. With a performance of 743.48% the BUY prediction by krebskrebs was a big success. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Avricore Health Inc. | 0.885% | 0.885% | -6.557% | 23.243% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% | 22.236% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% | 42.175% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% | 6.454% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% | 42.672% |
Comments by krebskrebs for this prediction
In the thread Avricore Health Inc. diskutieren
Buy mit Kursziel 0,01
In the thread Trading Avricore Health Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten